# Lexeo Therapeutics, Inc.: Form DEF 14A, filed Apr 28, 2025

- Company: [Lexeo Therapeutics, Inc.](/companies/lxeo.md) (CIK 1907108)
- Form: DEF 14A
- Filed: 2025-04-28
- Accepted by EDGAR: Apr 28, 2025, 16:46 ET
- Period: 2024-12-31
- Accession: 0000950170-25-059375
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1907108/000095017025059375/lxeo-def_14a-2025_proxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1907108/000095017025059375/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1907108/000095017025059375/lxeo-def_14a-2025_proxy.htm

Filed Apr 28, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-059375. Last ingested by Listed: Oct 29, 2026, 07:31 ET. No prices; not investment advice.